Keywords: update, serono, overturns, biogen, orphan, exclusivity, launches

Update: Serono overturns Biogen's US orphan exclusivity and launches Rebif

Article | 18 March 2002

Print This

Serono of Switzerland has launched its Rebif (interferon beta-1a)product for the treatment of multiple sclerosis in the USA, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in